EA
Review #1, NDA 20-358 |
Page 12 |
|
Water
use 0.08% total |
|
Energy
use 12% total |
|
Disposal 075% total natural gas use |
|
Drug Product |
|
Water
use 0.003% total |
|
Energy
use 0.08% |
|
Waste
disposal 0.01% total energy use |
|
Adequate |
|
|
|
b. Effect on endangered or threatened species and property
listed in or eligible for listing in the National
Register of Historic Places: |
|
The
assessment states that the permitted activities were judged not likely to
jeopardize critical habitat
nor would the activity impact property listed in or eligible for listing in
the National Registry of
Historic Places. |
|
Adequate. |
|
|
10. |
Mitigation measures: |
|
The company cites various procedures to
mitigate release of compounds into the environment including measures
descried in 6b. Also included is a
list of titles and brief description of several standard operating procedures
relevant to avoiding or mitigating adverse environmental impacts. |
|
Adequate. |
|
|
11. |
Alternatives to the proposed action: |
|
Eliminating the production of this product
is listed as a no action alternative. |
|
Adequate. |
|
|
12. |
List of Preparers and their qualifications: |
|
A list of preparers is provided. Personnel from the contract testing
laboratory are cited as being listed in the attachments describing the
contracted studies, but their qualifications are not contained in the
report. A statement |
Back a Page
Next Page
Back to Wellbutrin SRŪ NDA Index Page
Back to Main
Index